We Help Companies Find New Sales Opportunities
CeNes, the Cambridge-based pharmaceuticals manufacturer with 15 staff, is to be acquired by Paion of Germany for £11m.
CeNes is to raise £11m in a share placing to fund the development of a pain relief drug.
CeNes Pharmaceuticals has acquired TheraSci, the developer of drugs for the central nervous system, for up to £3.7m.
CeNes Pharmaceuticals has sold its ion channel technology development business to Xention Discovery, a new Cambridge-based company backed by venture capitalist MVM, for £0.8m.
CeNes Pharmaceuticals has sold its cognitive testing division to a management team operating under the name of Cambridge Cognition for up to £1m.
CeNes Pharmaceuticals has acquired Management Dynamics Cambridge, a specialist organisational psychology company, and merged it with its own cognition division to create a new business called Cambridge Cognition.